- 1996–2009: HIPAA and the MMA fixed transaction standards, including the X12 278 for prior authorization.
- 2009–2018: HITECH pushed providers onto certified EHRs; payers were not in scope.
- Since 2020: CMS has pushed payers onto FHIR APIs, with CMS-9115-F for data access and CMS-0057-F for prior authorization.
- CMS-0062-P would extend both to drugs and make FHIR the HIPAA standard for prior authorization; it is still proposed, apart from a standards slice finalized August 4, 2026.
Thirty years of federal interoperability rules run in three phases. HIPAA and the MMA fixed transaction standards (1996-2009). HITECH pushed providers onto certified EHRs (2009-2018). Since 2020 CMS has pushed payers onto FHIR APIs: 9115 for data access, 0057 for prior authorization, and 0062-P to extend both to drugs and make FHIR the HIPAA PA standard. As of November 17, 2026, CMS-0057-F’s 2027 API dates stand, and CMS-0062 is proposed except for an ONC standards slice finalized August 4, 2026.
Snapshot: the mandates at a glance
| Date | Type | Rule / citation | Proposed | Effective | Compliance | Applies to | Key requirements | Standards / IGs | Section |
|---|---|---|---|---|---|---|---|---|---|
| 1996-08-21 | Statute | HIPAA, Pub. L. 104-191, Title II Subtitle F | n/a | n/a | n/a | Health plans, clearinghouses, providers that transact electronically | HHS to adopt national transaction, code set and identifier standards | Left to rulemaking | Precursors |
| 2000-08-17 | Final | HIPAA Transactions and Code Sets, HCFA-0149-F, 65 FR 50312 | not checked | 2000-10-16 | 2002-10-16; small plans 2003-10-16; ASCA extension to 2003-10-16 | HIPAA covered entities | First mandated EDI set, including the 278 PA transaction | X12N 4010; NCPDP Telecom 5.1 | Precursors |
| 2003-02-20 | Final | HIPAA modifications, 68 FR 8381 | not checked | 2003-03-24 | 2003-10-16 | HIPAA covered entities | Corrected the 2000 adoption | X12N 4010A1; NCPDP Batch 1.1 | Precursors |
| 2003-12-08 | Statute | MMA, Pub. L. 108-173, SSA 1860D-4(e) | n/a | n/a | n/a | Part D sponsors; e-prescribing prescribers and pharmacies | Part D sponsors must support adopted e-Rx standards | Left to rulemaking | Precursors |
| 2005-11-07 | Final | Part D e-Rx foundation standards, CMS-0011-F, 70 FR 67568 | not checked | 2006-01-01 | 2006-01-01 | Part D sponsors; e-prescribing prescribers and pharmacies | New Rx, eligibility, pharmacy claims | SCRIPT 5.0; X12 270/271; NCPDP Telecom 5.1 | Precursors |
| 2008-04-07 | Final | Part D e-Rx second set, 73 FR 18918 | not checked | 2008-06-06 | 2009-04-01 (SCRIPT 8.1) | Part D sponsors; e-prescribing prescribers and pharmacies | Formulary, medication history, NPI | F&B 1.0; SCRIPT 8.1; NPI | Precursors |
| 2009-01-16 | Final | HIPAA 5010/D.0, CMS-0009-F, 74 FR 3296; ICD-10 same day, 74 FR 3328 | not checked | 2009-03-17 | 2012-01-01; enforcement discretion to 2012-06-30; ICD-10 2015-10-01 | HIPAA covered entities | Upgraded every HIPAA transaction | X12 5010 (278 = 005010X217); NCPDP D.0, Batch 1.2, Subrogation 3.0 | Precursors |
| 2009-02-17 | Statute | HITECH (ARRA), Pub. L. 111-5 | n/a | n/a | n/a | Eligible professionals, hospitals, CAHs | EHR incentives for meaningful use of certified EHR; codified ONC | Left to ONC certification | HITECH |
| 2010-03-23 | Statute | ACA 1104, Pub. L. 111-148 | n/a | n/a | n/a | HIPAA covered entities | Operating rules, EFT standard, attachments mandate | Left to rulemaking | Precursors |
| 2010-07-28 | Final | MU Stage 1, CMS-0033-F, 75 FR 44314; 2011 Edition, 75 FR 44590 | 2010-01-13 | 2010-09-27 | Program year 2011 | Eligible professionals, hospitals, CAHs | E-Rx; test exchange of key clinical information; patient electronic copy | 2011 Edition CEHRT | HITECH |
| 2011-07-08 | IFC | Eligibility and claim status operating rules, 76 FR 40458 | n/a | 2011-06-30 | 2013-01-01 | HIPAA covered entities | Operating rules for 270/271 and 276/277 | CAQH CORE Phase I/II | Precursors |
| 2012-01-10 | IFC | EFT standard, 77 FR 1556 | n/a | 2012-01-10 | 2014-01-01 | Health plans, providers | Standard for health care EFT | X12 CCD+ | Precursors |
| 2012-08-10 | IFC | EFT/ERA operating rules, 77 FR 48008 | n/a | 2012-08-10 | 2014-01-01 | HIPAA covered entities | Operating rules for EFT and 835 | CAQH CORE Phase III | Precursors |
| 2012-09-04 | Final | MU Stage 2, CMS-0044-F, 77 FR 53968; 2014 Edition, 77 FR 54163 | not checked | 2012-11-05 | From 2014 | Eligible professionals, hospitals, CAHs | Patient View/Download/Transmit; summary of care on transitions; secure messaging | C-CDA; Direct | HITECH |
| 2012-11-16 | Final | CY2013 PFS, 77 FR 68892 | not checked | not checked | 2013-11-01 | Part D sponsors, prescribers, pharmacies | Part D e-Rx moved to SCRIPT 10.6 | SCRIPT 10.6 | Precursors |
| 2015-04-16 | Statute | MACRA, Pub. L. 114-10 | n/a | n/a | n/a | Clinicians | Folded clinician MU into MIPS | n/a | HITECH |
| 2015-10-16 | Final | MU Stage 3, CMS-3310-FC, 80 FR 62762; 2015 Edition, 80 FR 62602 | not checked | 2015-12-15 | Optional 2017; required 2018 | Eligible professionals, hospitals, CAHs | Patient API access; HIE objective | 2015 Edition (g)(7)-(g)(9) | HITECH |
| 2016-11-04 | Final | QPP, CMS-5517-FC, 81 FR 77008 | not checked | 2017-01-01 | Performance year 2017 | MIPS clinicians | Advancing Care Information replaced clinician MU | 2014 or 2015 Edition CEHRT | HITECH |
| 2016-12-13 | Statute | 21st Century Cures Act, Pub. L. 114-255 | n/a | n/a | n/a | Health IT developers, HINs/HIEs, providers | Information blocking ban; APIs “without special effort”; TEFCA | Left to ONC | Cures / 9115 |
| 2018-04-16 | Final | CY2019 MA/Part D, CMS-4182-F, 83 FR 16440 | not checked | 2018-06-15 | 2020-01-01 | Part D sponsors, prescribers, pharmacies | Part D e-Rx moved to SCRIPT 2017071 | SCRIPT 2017071 | Precursors |
| 2018-08-17 | Final | FY2019 IPPS, CMS-1694-F, 83 FR 41144 | not checked | 2018-10-01 | CY2019 reporting | Hospitals, CAHs | MU renamed Promoting Interoperability (MIPS rename in CY2019 PFS, 83 FR 59452, 2018-11-23) | 2015 Edition CEHRT | HITECH |
| 2018-10-24 | Statute | SUPPORT Act, Pub. L. 115-271 | n/a | n/a | n/a | Part D sponsors, prescribers | EPCS for Part D controlled substances; Part D ePA | Left to rulemaking | Precursors |
| 2019-05-23 | Final | Part D real-time benefit tool, CMS-4180-F, 84 FR 23832 | not checked | not checked | 2021-01-01 | Part D sponsors | Support at least one prescriber real-time benefit tool | No named standard | Precursors |
| 2020-05-01 | Final | CMS Interoperability and Patient Access, CMS-9115-F, 85 FR 25510 | 2019-03-04 | 2020-06-30 | APIs 2021-01-01 (enforced 2021-07-01); ADT 2021-05-01; payer-to-payer 2022-01-01 (deferred); dual-eligible data 2022-04-01 | MA, Medicaid, CHIP, FFE QHP issuers; hospitals and CAHs (ADT CoP) | Patient Access and Provider Directory APIs; payer-to-payer; ADT notifications | FHIR R4, US Core 3.1.1, SMART via 170.215; CARIN BB, PDex, Plan-Net recommended | Cures / 9115 |
| 2020-05-01 | Final | ONC Cures Act rule, 85 FR 25642 | 2019-03-04 | 2020-06-30 | Information blocking 2021-04-05; Cures Update 2022-12-31 | Health IT developers, HINs/HIEs, providers | (g)(10) API; USCDI; information blocking exceptions; EHI export | FHIR R4, US Core 3.1.1, SMART, Bulk Data, USCDI v1 | Cures / 9115 |
| 2020-11-04 | IFC | ONC COVID IFC, 85 FR 70064 | n/a | 2020-12-04 | Moved information blocking date to 2021-04-05 | Same as the Cures rule | Extended Cures compliance dates | n/a | Cures / 9115 |
| 2020-12-18 | Proposed | CMS-9123-P, 85 FR 82586 | 2020-12-18 | n/a (never finalized) | n/a (withdrawn 2022-12-13) | Medicaid, CHIP, FFE QHP issuers; not MA | Provider Access, Payer-to-Payer and PA APIs; PA timeframes | FHIR R4; CRD, DTR, PAS, PDex, Bulk Data | 9123 |
| 2020-12-28 | Final | CY2021 PFS, 85 FR 84472 | not checked | 2021-01-01 | 2022-01-01; compliance actions from 2023-01-01 | Part D prescribers | EPCS for Part D controlled substances | SCRIPT 2017071 | Precursors |
| 2020-12-31 | Final | Part D ePA, CMS-4189-F, 85 FR 86824 | not checked | 2021-02-01 | Permitted 2021-01-01; required 2022-01-01 | Part D sponsors, prescribers | Part D electronic prior authorization | SCRIPT 2017071 ePA transactions | Precursors |
| 2021-12-10 | Notice | Payer-to-payer enforcement discretion, 86 FR 70412 | n/a | 2021-12-10 | Payer-to-payer not enforced pending new rule | 9115 impacted payers | Deferred 9115 payer-to-payer | n/a | Cures / 9115 |
| 2022-01-19 | Notice | TEFCA Common Agreement v1, 87 FR 2800 | n/a | n/a | Voluntary | QHINs and participants | National exchange framework | QTF; FHIR under CA v2.0 | ONC track |
| 2024-01-09 | Final | HTI-1, 89 FR 1192 | 2023-04-18 (88 FR 23746) | 2024-02-08 | USCDI v3 by 2026-01-01 | Health IT developers | Edition-less certification; USCDI v3 baseline; DSI; information blocking changes | USCDI v3, US Core 6.1.0, SMART 2.0.0 | ONC track |
| 2024-02-08 | Final | CMS Interoperability and Prior Authorization, CMS-0057-F, 89 FR 8758 | 2022-12-13 (87 FR 76238) | 2024-04-08 | PA timeframes, denial reasons, metrics 2026-01-01; APIs 2027-01-01; ePA measure CY2027 | MA, Medicaid and CHIP FFS and managed care, FFE QHP issuers; MIPS clinicians, hospitals, CAHs | Provider Access, Payer-to-Payer, PA APIs; PA data in Patient Access; 72-hour and 7-day decisions; public metrics | FHIR R4, US Core, SMART, Bulk Data; CRD, DTR, PAS, PDex, CARIN BB, Plan-Net recommended | 0057 |
| 2024-06-17 | Final | Part D and Health IT Standards, CMS-4205-F2, 89 FR 51238 | not checked | 2024-07-17 | F&B and RTPB 2027-01-01; SCRIPT 2023011 2028-01-01 | Part D sponsors, prescribers, pharmacies | Updated Part D e-Rx and ePA standards; real-time benefit standard | SCRIPT 2023011; F&B 60; RTPB 13 | Precursors |
| 2024-07-01 | Final | Information blocking disincentives, 89 FR 54662 | 2023-11-01 | 2024-07-31 | n/a | Providers in MIPS, PI hospitals, ACOs | Disincentives for providers found to block information | n/a | ONC track |
| 2024-08-05 | Proposed | HTI-2 proposed, 89 FR 63498 | 2024-08-05 | n/a (payer criteria never finalized) | n/a (remaining proposals withdrawn 2025-12-29, 90 FR 60602) | Health IT developers, including payer-side | Payer API certification criteria (g)(30)-(g)(36); TEFCA; provider ePA | USCDI v4; CRD, DTR, PAS, PDex | ONC track |
| 2024-12-13 | Final | HIPAA pharmacy standards, CMS-0056-F, 89 FR 100763 | not checked | 2025-04-14 (after delay) | 2028-04-14 | HIPAA covered entities, pharmacies | Upgraded retail pharmacy transactions | NCPDP Telecom F6, Batch 15, Subrogation 10 | Precursors |
| 2024-12-16 | Final | HTI-2 final (TEFCA), 89 FR 101772 | 2024-08-05 | 2025-01-15 | n/a | QHINs | Codified TEFCA at 45 CFR part 172 | n/a | ONC track |
| 2024-12-17 | Final | HTI-3, 89 FR 102512 | 2024-08-05 | 2024-12-17 | n/a | Information blocking actors | Protecting Care Access exception | n/a | ONC track |
| 2025-08-04 | Final | HTI-4 in FY2026 IPPS, CMS-1833-F, 90 FR 36536 | 2024-08-05 (in HTI-2 proposed) | 2025-10-01 | 2028-01-01 | Health IT developers (provider side) | Provider ePA criteria; e-Rx and RTPB criteria; no payer criteria | CRD, DTR, PAS 2.0.1; SCRIPT 2023011; RTPB 13 | ONC track |
| 2026-03-24 | Final | Attachments and e-signatures, CMS-0053-F, 91 FR 14350 | 2022-12-21 (87 FR 78438) | 2026-05-26 | 2028-05-26 | HIPAA covered entities | Claims attachments standard; PA attachments not finalized | X12 275/277 v6020; HL7 C-CDA; HL7 attachments IG | Precursors |
| 2026-04-14 | Proposed | CMS-0062-P, 91 FR 19890 | 2026-04-14 | n/a (pending, except the ONC slice) | Proposed 2027-10-01; HIPAA FHIR 24 months after effective date, 36 for small plans | 0057 payers; HIPAA covered entities | Drug PA on the APIs and NCPDP rail; FHIR replaces X12 278 for PA; IGs required; endpoint reporting; more metrics | FHIR R4, US Core 6.1.0, SMART 2.0.0, CRD 2.2.1, DTR 2.2.0, PAS 2.2.1, CDex 2.1.0; SCRIPT 2023011 | 0062 |
| 2026-08-04 | Final | FY2027 IPPS, CMS-1849-F and CMS-0062-F, 91 FR 49570 | 2026-04-14 | 2026-10-01 | Older IG versions expire 2028-01-01; hospital ePA measure bonus CY2027, required CY2028 | Health IT developers; hospitals, CAHs | Finalized the ONC rider from 0062-P | CRD 2.2.1, DTR 2.2.0, PAS 2.2.1, US Core 6.1.0 | 0062 |
| 2026-10-28 | Final | HTI-5, 91 FR 67916 | 2025-12-29 (90 FR 60970) | 2026-12-28 (secondary source) | not checked | Health IT developers | Deregulatory; reported to keep HTI-4 ePA and RTPB criteria | not checked | ONC track |
| 2026-11-09 | Final | CY2027 PFS, FR Doc 2026-22743 | not checked | not checked | MIPS ePA bonus CY2027, required CY2028; drug ePA measure from CY2028 (AMA summary only) | MIPS clinicians | ePA measure changes | n/a | 0057 |
How to read the table. Rows run oldest to newest by the date in the first column: Federal Register publication for rules and notices, enactment for statutes, and publication for proposed rules that never became final. All dates are YYYY-MM-DD. “n/a” means the field doesn’t apply, such as a proposed date for a statute. “not checked” means I didn’t confirm that value against the primary source. The Section column points to where each row is discussed below. The narrative is grouped by track (HIPAA and Part D, HITECH, Cures, payer rules, ONC), so within a section the order is chronological but sections overlap in time.
Precursors (1996-2008): HIPAA transactions and Part D e-prescribing
Before “interoperability” was a CMS program word, two statutes set the transaction plumbing that every later rule either built on or tried to replace: HIPAA for administrative transactions, and the MMA for Part D e-prescribing. Both use the same mechanism: HHS adopts a named standard version by regulation, and moving to the next version takes another rule.
HIPAA Administrative Simplification
- Statute. Pub. L. 104-191, August 21, 1996, Title II Subtitle F (42 U.S.C. 1320d et seq.) (govinfo).
- Transactions and Code Sets rule. 65 FR 50312, August 17, 2000 (HCFA-0149-F). X12N 4010 for claims, eligibility (270/271), claim status, remittance and the 278 referral certification and authorization transaction; NCPDP Telecommunication 5.1 for retail pharmacy. Compliance October 16, 2002 (small plans October 16, 2003); ASCA (Pub. L. 107-105, Dec 27, 2001) let filers of compliance plans move to October 16, 2003.
- 2003 modifications. 68 FR 8381, February 20, 2003: X12N 4010A1 addenda; NCPDP Batch 1.1 replaced Batch 1.0, which the 2000 rule had “adopted in error.”
- 5010 and D.0. 74 FR 3296, January 16, 2009 (CMS-0009-F): X12 5010 (278 becomes 005010X217), NCPDP D.0 and Batch 1.2, Medicaid Subrogation 3.0. Compliance January 1, 2012; CMS enforcement discretion ran through June 30, 2012. ICD-10 followed the same day (74 FR 3328), finally effective October 1, 2015 after two delays.
- ACA §1104 operating rules. Eligibility and claim status (76 FR 40458, July 8, 2011; CAQH CORE Phase I/II; compliance January 1, 2013). EFT standard (77 FR 1556, January 10, 2012) and EFT/ERA operating rules (77 FR 48008, August 10, 2012), compliance January 1, 2014.
- Recent HIPAA rules that 0062 leans on. NCPDP Telecommunication F6, Batch 15 and Subrogation 10 (89 FR 100763, December 13, 2024, CMS-0056-F; after a freeze delay and an August 2025 interim final rule, full compliance is April 14, 2028). Claims attachments and electronic signatures (91 FR 14350, March 24, 2026, CMS-0053-F): X12 275/277 v6020, HL7 C-CDA and the HL7 attachments IG for claims, compliance May 26, 2028. Prior authorization attachments proposed in 2022 were not finalized; 0062-P now proposes CDex for them instead.
The X12 278 is the key fact for the rest of this story. It has been the HIPAA PA standard since 2003. The 0057 PA API runs on FHIR only under HHS enforcement discretion, and 0062-P proposes to replace the 278 with FHIR for PA.
MMA 2003 and Part D e-prescribing
- Statute. Pub. L. 108-173, December 8, 2003; SSA §1860D-4(e) required Part D sponsors to support e-prescribing standards.
- Foundation standards. 70 FR 67568, November 7, 2005 (CMS-0011-F), effective January 1, 2006: NCPDP SCRIPT 5.0, X12 270/271, NCPDP Telecommunication 5.1.
- Second set. 73 FR 18918, April 7, 2008, effective June 6, 2008: Formulary & Benefit 1.0, medication history and fill status (SCRIPT 8.1), NPI; SCRIPT 8.1 required April 1, 2009.
- Version march. SCRIPT 10.6 mandatory from November 1, 2013 (CY2013 PFS, 77 FR 68892). SCRIPT 2017071 from January 1, 2020 (CY2019 MA/Part D rule, 83 FR 16440, April 16, 2018). Part D sponsors had to support at least one prescriber real-time benefit tool by January 1, 2021 (84 FR 23832, May 23, 2019).
- SUPPORT Act (Pub. L. 115-271, October 24, 2018). §2003 required EPCS for Part D controlled substances from January 1, 2021 (CMS compliance actions from January 1, 2023). §6062 required Part D electronic prior authorization, implemented by the Secure Electronic Prior Authorization for Part D rule (85 FR 86824, December 31, 2020, CMS-4189-F): SCRIPT 2017071 ePA transactions permitted January 1, 2021 and required January 1, 2022.
- 2024 Part D and Health IT Standards rule (89 FR 51238, June 17, 2024, CMS-4205-F2): F&B 60 and RTPB 13 required January 1, 2027; SCRIPT 2023011 required for e-Rx and ePA January 1, 2028.
So Part D had a mandatory NCPDP ePA rail years before medical-benefit PA had any working electronic mandate. 0057 left drugs out for that reason; 0062-P proposes to extend that NCPDP rail to Medicaid, CHIP and QHPs.
HITECH and Meaningful Use (2009-2018): interoperability by incentive, aimed at providers
HITECH made interoperability a provider obligation, paid for with incentives and later penalties; payers were not in scope. It was enacted in ARRA, Pub. L. 111-5, signed February 17, 2009 (govinfo). It codified ONC and funded the Medicare and Medicaid EHR Incentive Programs. CMS set what “meaningful use” of certified EHR technology (CEHRT) meant; ONC certified the technology. Every stage came as a CMS program rule paired with an ONC certification rule on the same day.
| Stage | CMS rule | ONC certification rule | Interoperability content |
|---|---|---|---|
| Stage 1 | CMS-0033-F, 75 FR 44314, July 28, 2010 | 2011 Edition, 75 FR 44590, July 28, 2010 | Data capture; e-prescribing; a test exchange of key clinical information; patient electronic copies. Program began 2011. |
| Stage 2 | CMS-0044-F, 77 FR 53968, Sept 4, 2012 | 2014 Edition, 77 FR 54163, Sept 4, 2012 | Patient View/Download/Transmit; summary of care on transitions (C-CDA, Direct transport); secure messaging. |
| Stage 3 and 2015-2017 modifications | CMS-3310-FC / 3311-FC, 80 FR 62762, Oct 16, 2015 | 2015 Edition, 80 FR 62602, Oct 16, 2015 | Patient access through APIs (2015 Edition (g)(7)-(g)(9)); health information exchange objective. Stage 3 optional in 2017, required from 2018 per the rule; later rules added flexibility. |
MACRA (Pub. L. 114-10, April 16, 2015) folded the physician side into the Quality Payment Program (CMS-5517-FC, 81 FR 77008, Nov 4, 2016, effective Jan 1, 2017). Meaningful use for clinicians became the MIPS “Advancing Care Information” category.
Rename to Promoting Interoperability (2018). CMS announced the rename on April 24, 2018 (press release) and finalized it for hospitals in the FY2019 IPPS/LTCH final rule (CMS-1694-F, 83 FR 41144, Aug 17, 2018, effective Oct 1, 2018). The MIPS category took the same name in the CY2019 PFS final rule (83 FR 59452, Nov 23, 2018). The rename signalled the pivot: from “use the EHR” to “exchange the data and give patients API access.” That pivot is what later carried a prior-authorization measure into MIPS and the hospital program under 0057.
The gap HITECH left was the payer. Clinicians had certified FHIR-capable systems; plans had no matching obligation. Closing that gap is the story of 9115, 0057 and 0062.
Cures Act and the 2020 twin rules: payers enter the frame (CMS-9115-F and ONC’s Cures rule)
The 21st Century Cures Act (Pub. L. 114-255, December 13, 2016) gave HHS three tools: certification conditions requiring APIs usable “without special effort” (§4002), a trusted exchange framework, TEFCA (§4003), and a ban on information blocking (§4004). On May 1, 2020 HHS published two rules that used them together. ONC’s rule set the technical floor for certified health IT. CMS’s rule put payers on that floor for the first time.
ONC 21st Century Cures Act final rule
85 FR 25642, May 1, 2020 (RIN 0955-AA01), effective June 30, 2020.
- USCDI v1 replaced the Common Clinical Data Set.
- Standardized API criterion 170.315(g)(10) on FHIR R4 (4.0.1), US Core 3.1.0, SMART App Launch 1.0.0, OpenID Connect Core 1.0 and Bulk Data 1.0.0, codified in 45 CFR 170.215. CMS-9115-F cross-referenced these same standards for payers.
- Information blocking at 45 CFR part 171, with eight exceptions (five for not fulfilling a request, three for procedures). Later rules took it to ten: HTI-1 split out Manner and added a TEFCA Manner exception; HTI-3 added Protecting Care Access.
- COVID interim final rule (85 FR 70064, November 4, 2020): information blocking applicability moved to April 5, 2021; EHI limited to USCDI until October 6, 2022; Cures Update criteria, including (g)(10), due December 31, 2022.
- Teeth for providers came later, in the information blocking disincentives rule (89 FR 54662, July 1, 2024): hospitals lose meaningful-user status (three-quarters of the market basket update); CAHs drop from 101% to 100% of cost; MIPS clinicians get zero in Promoting Interoperability; ACOs can be removed from or denied MSSP participation for at least a year.
CMS-9115-F Interoperability and Patient Access
85 FR 25510, May 1, 2020 (RIN 0938-AT79), effective June 30, 2020; proposed at 84 FR 7610, March 4, 2019. The rule’s own label is the “impacted payers” that every later rule inherits: MA organizations, Medicaid and CHIP FFS programs, Medicaid managed care plans, CHIP managed care entities, and QHP issuers on the FFEs.
| Provision | Who | Requirement | Date |
|---|---|---|---|
| Patient Access API | All impacted payers | FHIR R4 API exposing claims and encounter data (within 1 business day of adjudication) and USCDI clinical data, for dates of service from January 1, 2016, to third-party apps the member chooses | January 1, 2021; CMS did not enforce until July 1, 2021 (COVID) |
| Provider Directory API | MA, Medicaid, CHIP (not QHPs on FFEs) | Public FHIR API with provider names, addresses, phone numbers, specialties; MA-PDs add pharmacy directory | January 1, 2021; enforced from July 1, 2021 |
| Payer-to-payer exchange | MA, Medicaid managed care, CHIP managed care, QHPs on FFEs | On member request, exchange USCDI data with prior and new payers, covering 5 years | January 1, 2022; CMS used enforcement discretion from December 10, 2021 (86 FR 70412) pending new rulemaking, which became 0057 |
| Dual-eligible data exchange | States | Daily MMA file and buy-in data exchange with CMS | April 1, 2022 |
| ADT event notifications | Hospitals, psychiatric hospitals, CAHs | Condition of Participation: send admission, discharge and transfer notifications to the patient’s providers | May 1, 2021 (12 months after publication) |
| Public reporting | Clinicians and hospitals | Identify those who attest negatively on information blocking; publish providers lacking digital contact info in NPPES | Late 2020 / second half of 2020 |
Standards were required at the base layer only (45 CFR 170.215: FHIR R4, US Core, SMART, OpenID Connect). CARIN Blue Button, Da Vinci PDex, PDex US Drug Formulary and PDex Plan Net were recommended, not required. That split is the thread 0062-P picks up six years later, when it proposes to make those recommended IGs mandatory.
What 9115 did not do: prior authorization, provider-facing data access, and a workable payer-to-payer API. All three came next.
CMS-9123-P (2020): the prior authorization rule that never took effect
CMS-9123-P was the first draft of 0057; it stalled in the January 2021 regulatory freeze, and the biggest change on its restart was adding Medicare Advantage. It was published December 18, 2020 at 85 FR 82586 (RIN 0938-AT99), with a comment period of only about two weeks (to January 4, 2021).
- Scope. Medicaid and CHIP FFS, Medicaid and CHIP managed care, and QHP issuers on the FFEs. Not MA.
- Proposals. A FHIR Documentation Requirement Lookup Service and a Prior Authorization Support API (the CRD/DTR/PAS pattern under other names); a Provider Access API; a payer-to-payer API replacing 9115’s request-based exchange; 72-hour expedited and 7-day standard PA decision timeframes; a specific denial reason; public PA metrics.
- What happened. CMS released a final version on January 15, 2021 for the same payers, with 2024 compliance dates. It was never published in the Federal Register and was caught by the January 20, 2021 regulatory freeze. This rests on contemporaneous press reports, not a Federal Register document.
- Formal end. The 0057 proposed rule says CMS is “withdrawing the December 2020 CMS Interoperability proposed rule and issuing this new proposed rule” (87 FR 76238). Commenters had pressed the MA omission, and 0057 brought MA in.
Meanwhile Part D had its own statutory ePA mandate: the SUPPORT Act §6062 and the December 31, 2020 Part D ePA rule (SCRIPT 2017071, required January 1, 2022), covered under Precursors. That is why both 9123 and 0057 explicitly exclude drugs.
CMS-0057 (2022-2024): prior authorization and the full payer API set
CMS-0057-F finished what 9115 started. It brought MA into PA reform, added operational PA rules from 2026, and added three FHIR APIs from 2027. No delay or enforcement discretion for its dates had been announced as of November 17, 2026.
Proposed rule, CMS-0057-P
Released December 6, 2022, published December 13, 2022 at 87 FR 76238 (RIN 0938-AU87); comments to March 13, 2023. It withdrew 9123-P and added MA. It proposed Jan 1, 2026 for most provisions and called the PA API the “PARDD API” (Prior Authorization Requirements, Documentation and Decision). It proposed the Electronic Prior Authorization measure from CY2026.
Final rule, CMS-0057-F
Released January 17, 2024 (fact sheet), published February 8, 2024 at 89 FR 8758 (RIN 0938-AU87), effective April 8, 2024; correcting amendment at 89 FR 85070, October 25, 2024.
Impacted payers: MA organizations, Medicaid and CHIP FFS, Medicaid managed care plans, CHIP managed care entities, QHP issuers on the FFEs. Dates apply on the calendar date for MA and state FFS, to rating periods beginning on or after the date for Medicaid/CHIP managed care, and to plan years beginning on or after the date for QHPs.
| Provision | Requirement (MA cite) | Applies to | Date |
|---|---|---|---|
| PA decision timeframes | 72 hours expedited, 7 calendar days standard | MA, Medicaid, CHIP (not QHPs) | Jan 1, 2026 |
| Specific denial reason | To the provider, whatever channel the request came by (42 CFR 422.122(a)) | All impacted payers | Jan 1, 2026 |
| Public PA metrics | Annual web posting by March 31 of the prior year’s data: list of items/services needing PA; % standard approved, denied, approved after appeal; % approved after timeframe extension; % expedited approved, denied; average and median decision time, standard and expedited (422.122(c)) | All impacted payers; MA at contract level | First posting March 31, 2026 (CY2025 data) |
| Patient Access API usage metrics | Unique enrollees whose data went to an app, and to an app more than once, reported to CMS | All impacted payers | First report March 31, 2026 (CY2025) |
| Prior Authorization API | FHIR API that lists items/services needing PA, the documentation rules, accepts the request and returns approval, denial with reason, or request for more information (422.122(b)). Recommended IGs: Da Vinci CRD, DTR, PAS | All impacted payers | Jan 1, 2027 |
| Provider Access API | Claims/encounters (no cost-sharing or remittance), USCDI data and PA information for attributed patients, within 1 business day; patient opt-out; attribution process (422.121) | All impacted payers | Jan 1, 2027 |
| Payer-to-Payer API | Patient opt-in; 5 years of data; request within 1 week of opt-in; response within 1 business day; concurrent payers at least quarterly (422.121) | All impacted payers | Jan 1, 2027 |
| Patient Access API enhancement | Adds PA information, available within 1 business day and kept for at least 1 year after the last status change (422.119) | All impacted payers | Jan 1, 2027 |
| Electronic Prior Authorization measure | Yes/no attestation of at least one PA requested electronically through a payer PA API using CEHRT | MIPS clinicians; hospitals and CAHs | CY2027 as finalized; now a bonus in 2027 and required from 2028 (see below) |
Drugs are excluded throughout: from the PA API, the PA data in the other APIs, the timeframes, the denial reasons and the metrics. That gap is 0062’s reason for being.
Standards. Required: FHIR R4.0.1, US Core, SMART App Launch, Bulk Data (Provider Access and Payer-to-Payer), OpenID Connect (Patient Access), and USCDI, via 45 CFR 170.215. HTI-1 retired USCDI v1, US Core 3.1.1 and SMART 1.0.0 on January 1, 2026, leaving USCDI v3, US Core 6.1.0 and SMART 2.0.0. CARIN Blue Button, PDex, PDex US Drug Formulary, PDex Plan Net, CRD, DTR and PAS stay recommended, not required (CMS standards page).
HIPAA bridge. The X12 278 is still the HIPAA PA standard, so HHS announced enforcement discretion: covered entities may run an all-FHIR PAS-based PA API without converting to the 278. 0062-P proposes to end the need for discretion by making FHIR the HIPAA standard.
Later changes to the ePA measure. The FY2027 IPPS final rule made it an optional bonus for hospitals and CAHs in CY2027 and required from CY2028 (CMS ePA page). For MIPS, the CY2027 PFS final rule (published November 9, 2026) reportedly does the same and adds a drug ePA measure from CY2028. I could confirm that only from the AMA’s summary, not a CMS document.
Delay pressure. Stakeholders reportedly sought 2027 nonenforcement in September 2026, and the AMA urged CMS to hold the date. CMS has not responded publicly.
ONC’s parallel track (2022-2026): TEFCA, HTI-1 to HTI-5, and the 2025 policy push
ONC’s rules set the versions that CMS’s payer rules cross-reference, so each one moved the payer baseline. The provider side of ePA got a certification criterion in 2025; the payer side never did.
| Rule | Citation and date | What it did that matters for payers |
|---|---|---|
| TEFCA Common Agreement v1 | 87 FR 2800, Jan 19, 2022 | National framework; first QHINs designated Dec 12, 2023 (eHealth Exchange, Epic Nexus, Health Gorilla, KONZA, MedAllies). Common Agreement v2.0 (April 22, 2024) requires FHIR exchange. Voluntary for payers. |
| HTI-1 | 89 FR 1192, Jan 9, 2024 | USCDI v3 baseline (v1 expired Jan 1, 2026); US Core 6.1.0 and SMART 2.0.0; DSI criterion; editions dropped; information blocking Manner and TEFCA Manner exceptions. Moved the 0057 required versions. |
| HTI-2 proposed | 89 FR 63498, Aug 5, 2024 | Proposed payer-side certification criteria (g)(30)-(g)(36) for Patient Access, Provider Access, Payer-to-Payer, PA and Provider Directory APIs. None finalized; ONC withdrew the remaining HTI-2 proposals in December 2025 (90 FR 60602). |
| HTI-2 final (TEFCA) | 89 FR 101772, Dec 16, 2024 | Codified TEFCA at 45 CFR part 172. |
| HTI-3 | 89 FR 102512, Dec 17, 2024 | Protecting Care Access information blocking exception. Little payer relevance. |
| HTI-4 (in FY2026 IPPS final rule, CMS-1833-F) | 90 FR 36536, Aug 4, 2025, effective Oct 1, 2025 | Provider-side ePA criteria (g)(31) CRD, (g)(32) DTR, (g)(33) PAS on the Da Vinci 2.0.1 IGs; e-prescribing (b)(3) on SCRIPT 2023011 with ePA transactions mandatory (2023011 only from Jan 1, 2028); new (b)(4) RTPB v13, part of Base EHR from Jan 1, 2028. No payer-side criteria. |
| FY2027 IPPS final rule (CMS-1849-F and CMS-0062-F) | 91 FR 49570, Aug 4, 2026, effective Oct 1, 2026 | ONC rider from 0062-P finalized: CRD 2.2.1, DTR 2.2.0, PAS 2.2.1, US Core 6.1.0; older versions expire Jan 1, 2028. Hospital ePA measure: bonus 2027, required 2028. |
| HTI-5 (deregulatory) | 91 FR 67916, Oct 28, 2026 | Removes and revises a set of criteria; reported to leave the HTI-4 ePA and RTPB criteria intact. Details only from secondary summaries. |
2025 policy context (not rules). CMS and ONC issued a Health Technology Ecosystem RFI on May 16, 2025 (90 FR 21034, CMS-0042-NC). On June 23, 2025, HHS announced a voluntary payer pledge (CMS press release): FHIR-based ePA, fewer services under PA, honoring authorizations across plan switches, real-time decisions for most requests by 2027, clinician review of clinical denials. The CMS Interoperability Framework and “CMS Aligned Networks” pledge followed on July 30, 2025. The WISeR model (announced June 27, 2025) brought technology-assisted PA to Original Medicare in six states from January 1, 2026. These set the expectations that 0062-P then wrote into proposed regulation.
CMS-0062-P (2026): extending 0057 to drugs and moving PA onto FHIR under HIPAA
As of November 17, 2026, CMS-0062 is mostly still a proposed rule, with one slice already final. Comments closed June 15, 2026, and the CMS-0062-P page (last modified October 8, 2026) still labels it proposed.
The finalized slice. The ONC standards rider was pulled out and finalized in the FY2027 IPPS/LTCH final rule, docketed “CMS-1849-F and CMS-0062-F”, published August 4, 2026 at 91 FR 49570, effective October 1, 2026 (ONC announcement, July 31, 2026). It adopts CRD 2.2.1, DTR 2.2.0, PAS 2.2.1 and US Core 6.1.0 in 45 CFR 170.215(j), (k), (m) and (n), with the older versions expiring January 1, 2028. The same rule made the hospital and CAH Electronic Prior Authorization measure a bonus measure for CY2027 and required from CY2028. I found nothing showing the drug PA, HIPAA FHIR, endpoint, timeframe or metrics proposals finalized; treat those as pending.
Identity. “Interoperability Standards and Prior Authorization for Drugs” proposed rule, released April 10, 2026 (fact sheet), published April 14, 2026 at 91 FR 19890 (FR Doc. 2026-07205, RIN 0938-AV44, docket CMS-2026-1255). It is a joint CMS, HHS Office of the Secretary and ONC rule: a CMS program rule, a HIPAA Administrative Simplification rule and an ONC standards “rider” in one document.
What it does, in one line. 0057 built the API rails for non-drug items and services; 0062 runs drugs over the same rails, makes the 0057 “recommended” IGs mandatory, and proposes to make FHIR the HIPAA standard for prior authorization itself, which would reach every covered entity, not just the CMS-regulated payers.
Impacted payers. The 0057 set (MA organizations, Medicaid and CHIP FFS, Medicaid managed care plans, CHIP managed care entities, QHP issuers on the FFEs) plus a new one: small group market QHP issuers on the FF-SHOP. The HIPAA proposals apply to all covered entities (providers, plans, clearinghouses) that exchange PA transactions electronically.
Salient proposals
- Medical-benefit drugs on the Prior Authorization API. Impacted payers must add coverage and documentation requirements for drugs covered under a medical benefit (for MA, Part B drugs) to the CRD/DTR/PAS-based Prior Authorization API, from October 1, 2027.
- Pharmacy-benefit ePA on NCPDP. Medicaid and CHIP FFS, Medicaid and CHIP managed care, and FFE QHP issuers must support NCPDP SCRIPT 2023011 (ePA transactions), Formulary & Benefit, and Real-Time Prescription Benefit (cross-referenced to 45 CFR 170.205(b), (u) and (c)), from October 1, 2027. This aligns them with what Part D sponsors already carry. MA-PD Part D drugs stay under the Part D rules; this is the dual-rail model written into regulation.
- HIPAA: FHIR replaces X12 for PA-related transactions. HHS proposes FHIR R4.0.1, US Core STU 6.1.0, SMART App Launch 2.0.0, CRD 2.2.1, DTR 2.2.0 and PAS 2.2.1 as the standard for the “referral certification and authorization” transaction (CRD alone for the PA-related “eligibility for a health plan” transaction), in place of X12N 278 and 270/271 for those uses. An alternative would extend it to referral certifications. Da Vinci CDex 2.1.0 is proposed as the standard for attachments accompanying PA. Compliance: 24 months after the final rule’s effective date; 36 months for small health plans. Entities that don’t do electronic PA aren’t required to adopt it. The eligibility operating rules would be amended to carve out PA-related transmissions.
- Drug PA decision timeframes (from October 1, 2027). Medicaid FFS, Medicaid managed care and CHIP managed care: all drugs within 24 hours (aligning with the covered outpatient drug rule) or the 7-day/72-hour item-and-service clock, as the rule specifies. CHIP FFS: 24 hours for drugs with FFP. FFE QHP issuers: 72 hours standard, 24 hours expedited. MA is not given a new drug clock; CMS only asks for comment on a future 24-hour requirement for all MA drug PA.
- QHP issuers finally get the 0057 clock for non-drug items and services: 7 calendar days standard, 72 hours expedited, notice to the requesting provider, from October 1, 2027.
- Specific denial reason for drugs to the provider, for Medicaid/CHIP and QHP issuers, from October 1, 2027.
- Drug PA in the data APIs. Status, decision date, end date, drug and dosage, denial reason and provider-submitted documentation flow through the Patient Access and Provider Access APIs; Payer-to-Payer carries approved (not denied) drug PAs with structured and unstructured documentation. From October 1, 2027.
- Recommended IGs become required from October 1, 2027: CARIN Blue Button 2.0.0 (or 2.2.0), PDex 2.1.0, PDex US Drug Formulary 2.0.1 (or 2.1.0), PDex Plan Net 1.1.0 (or 1.2.0), CRD 2.0.1 (or 2.2.1), DTR 2.0.1 (or 2.2.0), PAS 2.0.1 (or 2.2.1). The older versions would expire January 1, 2028. CMS would cross-reference 45 CFR 170.215 so future ONC version updates flow through without new CMS rulemaking. Comment requested on FAST Security, Da Vinci ATR and CDex for later rulemaking.
- ONC rider. ONC proposes updated versions in 45 CFR 170.215(j), (k), (m) and (n), with currently adopted versions expiring January 1, 2028.
- Endpoint reporting. Payers report each interoperability API’s endpoint, FHIR capability statement URL and technical/registration documentation to CMS for central publication: within 60 days of the final rule’s effective date (existing payers), update within a week of changes, verify annually. Alternative: report via the National Directory of Healthcare Providers & Services (NDH) Endpoint profile.
- Metrics. Counts added to the 0057 percentages and new non-drug PA metrics (from the effective date); Medicaid/CHIP managed care report at plan and program level within 90 days of the rating period. New public drug PA metrics (MA: Part B drugs only) from 2028 for CY2027. New API usage metrics for Provider Access, Payer-to-Payer and Prior Authorization APIs from 2028 for CY2027.
- Outside interop: an Open Payments “failure to report” definition (CMP for not producing audit records within 30 days), and five RFIs: ADT event notifications for value-based care, cybersecurity resiliency, payer API oversight and testing (including use of the ONC certification program), step therapy, and PA for lab tests and DMEPOS.
The proposals rest on a standards base laid down since 2024: the 2024 Part D and Health IT Standards final rule (89 FR 51238), the HTI-4 final rule (90 FR 36536), the 2024 HIPAA NCPDP pharmacy standards final rule (89 FR 100763) and the 2026 HIPAA attachments final rule (91 FR 14350), all cited in the proposed rule’s preamble.
Primary sources
- HIPAA: Pub. L. 104-191; 45 CFR 162 subpart M; 5010 extension notice
- Part D e-prescribing: CMS e-prescribing standards; CMS EPCS program
- HITECH: Pub. L. 111-5; Promoting Interoperability press release
- Cures and 9115: Pub. L. 114-255; CMS interoperability and burden reduction page
- 0057: fact sheet; 42 CFR 422.119, 422.121, 422.122; CMS APIs and IGs page; CMS ePA page
- ONC: HTI-4 overview; ONC FY2027 IPPS standards announcement; TEFCA first QHINs; Common Agreement v2.0
- 0062: Federal Register; fact sheet; summary of provisions; comment guide; FY2027 IPPS final rule
- 2025 context: WISeR; Interoperability Framework